Chemoinformaics analysis of quercetin 3-O-glucuronide
| Molecular Weight | 478.362 | nRot | 4 |
| Heavy Atom Molecular Weight | 460.218 | nRig | 20 |
| Exact Molecular Weight | 478.075 | nRing | 4 |
| Solubility: LogS | -3.275 | nHRing | 2 |
| Solubility: LogP | 0.975 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 57.4983 |
| nHD | 8 | BPOL | 25.0017 |
| QED | 0.239 |
| Synth | 3.87 |
| Natural Product Likeliness | 1.684 |
| NR-PPAR-gamma | 0.813 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.376 |
| HIA | 0.737 |
| CACO-2 | -6.262 |
| MDCK | 0.00000681 |
| BBB | 0.252 |
| PPB | 0.983734 |
| VDSS | 0.782 |
| FU | 0.0202346 |
| CYP1A2-inh | 0.191 |
| CYP1A2-sub | 0.031 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.467 |
| CYP2d6-inh | 0.122 |
| CYP2d6-sub | 0.243 |
| CYP3a4-inh | 0.198 |
| CYP3a4-sub | 0.042 |
| CL | 7.942 |
| T12 | 0.56 |
| hERG | 0.054 |
| Ames | 0.817 |
| ROA | 0.361 |
| SkinSen | 0.833 |
| Carcinogencity | 0.735 |
| EI | 0.039 |
| Respiratory | 0.117 |
| NR-Aromatase | 0.837 |
| Antiviral | Yes |
| Prediction | 0.816682 |